MedPath

Vimpat

Brand Name: Vimpat

Generic Name: Lacosamide

Active
Registration Number

DR-XY43253

Dosage Form

Film-Coated Tablet

Issuance Date

August 15, 2024

Expiry Date

August 15, 2029

Product Information

Philippine FDA product specifications and classification details

Product Specifications

Dosage Strength100 mg
PackagingPVC/PVDC/Alu Blister Pack x 14's (Box of 14's and 56's)

Classification

C
Classification
Prescription Drug (RX)
P
Pharmacologic
Antiepileptic
A
Application
Initial (Variation)
Philippine FDA Classification

Active Ingredients (1)

Complete list of active ingredients in this pharmaceutical product.

LacosamideActive
Monograph: Lacosamide

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

MedPath - Medical Intelligence Platform